Steve Zhou

Does Clinical Inertia Vary By Personalized A1C Goal? A Study of Predictors And Prevalence of Clinical Inertia In A U.S. Managed-Care Setting

Jay Lin, Steve Zhou, Wenhui Wei et al. · Endocrine Practice · 2015 · 52 citations

Medicine, Internal Medicine, Managed Care +3

30-Day Readmission Among Elderly Medicare Beneficiaries with Type 2 Diabetes

Amit D. Raval, Steve Zhou, Wenhui Wei et al. · Population Health Management · 2015 · 52 citations

Medicine, Geriatric Medicine, Falls Prevention +16

Does Pen Help? A Real-World Outcomes Study of Switching from Vial to Disposable Pen Among Insulin Glargine-Treated Patients with Type 2 Diabetes Mellitus

Lin Xie, Steve Zhou, Wenhui Wei et al. · Diabetes Technology & Therapeutics · 2013 · 41 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacy Practice +17

Clinical and Economic Outcomes Among Patients With Diabetes Mellitus Initiating Insulin Glargine Pen Versus Vial

Michael Grabner, James W. Chu, Swetha Raparla et al. · Postgraduate Medicine · 2013 · 37 citations

Pharmacy, Internal Medicine, Pharmacoeconomics +17

Outcomes and Treatment Patterns of Adding a Third Agent to 2 OADs in Patients with Type 2 Diabetes

Philip Levin, Wenhui Wei, Steve Zhou et al. · Journal of Managed Care Pharmacy · 2014 · 34 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17